Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed.[A186841] Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a first line therapy for these indications since the development of newer antihypertensive medications.[T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779]
Synonyms
Hydralazin
Hydrazone 1(2H)-phthalazinone
6-Hydralazine
Hypophthalin
(2H)-Phthalazinone hydrazone
Hidralazina
Phthalazin-1-ylhydrazine
Hydralazine
(1Z)-1(2H)-Phthalazinone hydrazone
1-Hydrazinophthalazine
Hydralazinum
1-Phthalazinylhydrazine
Hydrallazine
Idralazina
Hydrazinophthalazine
Hydralazine hydrochloride
Brand Names
Isosorbide dinitrate and hydralazine hydrochloride
hydrALAZINE Hydrochloride
PMS-hydralazine
Asn-hydralazine
Hydralazine-50 Tab
Novo-hylazin Tab 25mg
Apo-hydralazine
Novo-hylazin Tab 10mg USP
Nu-hydral Tab 10mg
Jamp-hydralazine
Ser-Ap-Es
Apresoline hydrochloride
HydrALAZINE hydrochloride
BiDil
Nu-hydral Tab 25mg
Apresoline Tablets, 50mg
Hydralazine
Hydralazine HCl and Hydrochlorothiazide
Novo-hylazin Tab 50mg
HydrALAZINE Hydrochloride
Hydralazine-10 Tab 10mg
Hydralazine Hydrochloride Injection, USP
Mint-hydralazine
Apresoline Tablets, 10mg
Isosorbide Dinitrate and Hydralazine Hydrochloride
Hydralazine Hydrochloride
Apresoline Tablets, 25mg
Hydralazine Hydrochloride Injection
Hydralazine-25 Tab
Hydralazine Hydrocloride
Apresoline
Hydralazine HCl
Ser-AP-ES Tab
Nu-hydral Tab 50 mg
Indication
Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785]
Categories
Antihypertensive Agents
Antihypertensive Agents Indicated for Hypertension
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682